{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:12:39Z","timestamp":1774440759983,"version":"3.50.1"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T00:00:00Z","timestamp":1554163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100003407","name":"MIUR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Torino"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1093\/biolre\/ioz050","type":"journal-article","created":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T13:38:54Z","timestamp":1554212334000},"page":"1521-1535","source":"Crossref","is-referenced-by-count":11,"title":["Human recombinant FSH induces chemoresistance in human breast cancer cells via HIF-1\u03b1 activation\u2020"],"prefix":"10.1093","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0951-7340","authenticated-orcid":false,"given":"L","family":"Bergandi","sequence":"first","affiliation":[{"name":"Department of Oncology, University of Torino, Torino, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6402-6750","authenticated-orcid":false,"given":"S","family":"Canosa","sequence":"additional","affiliation":[{"name":"Gynecology and Obstetrics 1, Physiopathology of Reproduction and IVF Unit, Department of Surgical Sciences, S. Anna Hospital, University of Torino, Torino, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2124-7075","authenticated-orcid":false,"given":"G","family":"Pittatore","sequence":"additional","affiliation":[{"name":"Gynecology and Obstetrics 1, Physiopathology of Reproduction and IVF Unit, Department of Surgical Sciences, S. Anna Hospital, University of Torino, Torino, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8800-9135","authenticated-orcid":false,"given":"F","family":"Silvagno","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Torino, Torino, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7335-5801","authenticated-orcid":false,"given":"S","family":"Doublier","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Torino, Torino, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4390-9428","authenticated-orcid":false,"given":"G","family":"Gennarelli","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Torino, Torino, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1514-4771","authenticated-orcid":false,"given":"C","family":"Benedetto","sequence":"additional","affiliation":[{"name":"Gynecology and Obstetrics 1, Physiopathology of Reproduction and IVF Unit, Department of Surgical Sciences, S. Anna Hospital, University of Torino, Torino, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5797-3722","authenticated-orcid":false,"given":"A","family":"Revelli","sequence":"additional","affiliation":[{"name":"Gynecology and Obstetrics 1, Physiopathology of Reproduction and IVF Unit, Department of Surgical Sciences, S. Anna Hospital, University of Torino, Torino, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,4,2]]},"reference":[{"key":"2019061221400634600_bib1","author":"Global Cancer Observatory"},{"key":"2019061221400634600_bib2","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1158\/1055-9965.EPI-10-0437","article-title":"Global patterns of cancer incidence and mortality rates and trends","volume":"19","author":"Jemal","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2019061221400634600_bib3","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1200\/JCO.2018.78.1914","article-title":"Fertility preservation in patients with cancer: ASCO Clinical Practice Guideline Update","volume":"36","author":"Oktay","year":"2018","journal-title":"J Clin Oncol"},{"key":"2019061221400634600_bib4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2165\/00002018-200528050-00004","article-title":"Chemotherapy-induced ovarian failure","volume":"28","author":"Molina","year":"2005","journal-title":"Drug Saf"},{"key":"2019061221400634600_bib5","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.3802\/jgo.2016.27.e22","article-title":"Toward precision medicine for preserving fertility in cancer patients: existing and emerging fertility preservation options for women","volume":"27","author":"Kim","year":"2016","journal-title":"J Gynecol Oncol"},{"key":"2019061221400634600_bib6","first-page":"846","article-title":"Fertility preservation options in breast cancer patients","volume":"31","author":"Kasum","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"2019061221400634600_bib7","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3109\/09513590.2013.819083","article-title":"Is letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer?","volume":"29","author":"Revelli","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"2019061221400634600_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/525896","article-title":"Oocyte cryostorage to preserve fertility in oncological patients","volume":"2012","author":"Revelli","year":"2012","journal-title":"Obstet Gynecol Int"},{"key":"2019061221400634600_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5402\/2011\/350813","article-title":"Cryopreservation and fertility: current and prospective possibilities for female cancer patients","volume":"2011","author":"Campos","year":"2011","journal-title":"ISRN Obstet Gynecol"},{"key":"2019061221400634600_bib10","first-page":"290","article-title":"A specific controlled ovarian stimulation (COS) protocol for fertility preservation in women with breast cancer undergoing neoadjuvant chemotherapy","volume":"21","author":"Cavagna","year":"2017","journal-title":"Contemp Oncol Poznan Pol"},{"key":"2019061221400634600_bib11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12020-007-0041-8","article-title":"Differential role of gonadotropin-releasing hormone on human ovarian epithelial cancer cell invasion","volume":"31","author":"Chen","year":"2007","journal-title":"Endocrine"},{"key":"2019061221400634600_bib12","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.fertnstert.2014.05.017","article-title":"Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies","volume":"102","author":"Meirow","year":"2014","journal-title":"Fertil Steril"},{"key":"2019061221400634600_bib13","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.fertnstert.2011.01.003","article-title":"Breast cancer and fertility preservation","volume":"95","author":"Kim","year":"2011","journal-title":"Fertil Steril"},{"key":"2019061221400634600_bib14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.cct.2017.07.009","article-title":"Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: alternative versus standard stimulation protocols; the study protocol of the STIM-trial","volume":"61","author":"Dahhan","year":"2017","journal-title":"Contemp Clin Trials"},{"key":"2019061221400634600_bib15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.mce.2016.08.009","article-title":"LH and FSH promote migration and invasion properties of a breast cancer cell line through regulatory actions on the actin cytoskeleton","volume":"437","author":"Sanchez","year":"2016","journal-title":"Mol Cell Endocrinol"},{"key":"2019061221400634600_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fendo.2018.00239","article-title":"Regulatory actions of LH and follicle-stimulating hormone on breast cancer cells and mammary tumors in rats","volume":"9","author":"Sanchez","year":"2018","journal-title":"Front Endocrinol"},{"key":"2019061221400634600_bib17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","article-title":"Mechanisms of cancer drug resistance","volume":"53","author":"Gottesman","year":"2002","journal-title":"Annu Rev Med"},{"key":"2019061221400634600_bib18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0015-0282(16)56646-1","article-title":"Clinical pharmacology of recombinant human follicle-stimulating hormone. III. Pharmacokinetic-pharmacodynamic modeling after repeated subcutaneous administration","volume":"61","author":"Porchet","year":"1994","journal-title":"Fertil Steril"},{"key":"2019061221400634600_bib19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1476-4598-12-137","article-title":"Omega 3 fatty acids chemosensitize multidrug resistant colon cancer cells by down-regulating cholesterol synthesis and altering detergent resistant membranes composition","volume":"12","author":"Gelsomino","year":"2013","journal-title":"Mol Cancer"},{"key":"2019061221400634600_bib20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cbi.2009.11.021","article-title":"Fluoride-containing bioactive glasses inhibit pentose phosphate oxidative pathway and glucose 6-phosphate dehydrogenase activity in human osteoblasts","volume":"183","author":"Bergandi","year":"2010","journal-title":"Chem Biol Interact"},{"key":"2019061221400634600_bib21","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1021\/mp2001389","article-title":"Liposome-encapsulated doxorubicin reverses drug resistance by inhibiting P-glycoprotein in human cancer cells","volume":"8","author":"Riganti","year":"2011","journal-title":"Mol Pharmaceutics"},{"key":"2019061221400634600_bib22","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1177\/1933719114525268","article-title":"Inducible nitric oxide synthase and heme oxygenase 1 are expressed in human cumulus cells and may be used as biomarkers of oocyte competence","volume":"21","author":"Bergandi","year":"2014","journal-title":"Reprod Sci"},{"key":"2019061221400634600_bib23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"2019061221400634600_bib24","doi-asserted-by":"crossref","first-page":"17078","DOI":"10.1038\/cddiscovery.2017.78","article-title":"Parthenolide prevents resistance of MDA-MB231 cells to doxorubicin and mitoxantrone: the role of Nrf2","volume":"3","author":"Carlisi","year":"2017","journal-title":"Cell Death Discov"},{"key":"2019061221400634600_bib25","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1200\/JCO.2005.02.6187","article-title":"Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update","volume":"24","author":"Kaufmann","year":"2006","journal-title":"J Clin Oncol"},{"key":"2019061221400634600_bib26","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1038\/sj.onc.1210169","article-title":"YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt\/NF-\u00ce\u00baB signaling to HIF-1\u00ce\u00b1 accumulation during hypoxia","volume":"26","author":"Sun","year":"2007","journal-title":"Oncogene"},{"key":"2019061221400634600_bib27","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1183\/09031936.00090407","article-title":"Asbestos induces doxorubicin resistance in MM98 mesothelioma cells via HIF-1\u00c2","volume":"32","author":"Riganti","year":"2008","journal-title":"Eur Respir J"},{"key":"2019061221400634600_bib28","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/j.1476-5381.2009.00117.x","article-title":"Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glycoprotein overexpression","volume":"156","author":"Riganti","year":"2009","journal-title":"Br J Pharmacol"},{"key":"2019061221400634600_bib29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2407-12-4","article-title":"HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast","volume":"12","author":"Doublier","year":"2012","journal-title":"BMC Cancer"},{"key":"2019061221400634600_bib30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1248\/bpb.b16-00684","article-title":"Cobalt chloride induces expression and function of breast cancer resistance protein (BCRP\/ABCG2) in human renal proximal tubular epithelial cell line HK-2","volume":"40","author":"Nishihashi","year":"2017","journal-title":"Biol Pharm Bull"},{"key":"2019061221400634600_bib31","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2147\/OTT.S82835","article-title":"Hypoxia-inducible factor-1α induces multidrug resistance protein in colon cancer","volume":"8","author":"Lv","year":"2015","journal-title":"Onco Targets Ther"},{"key":"2019061221400634600_bib32","first-page":"3387","article-title":"Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene","volume":"62","author":"Comerford","year":"2002","journal-title":"Cancer Res"},{"key":"2019061221400634600_bib33","doi-asserted-by":"crossref","first-page":"19431","DOI":"10.1074\/jbc.M401235200","article-title":"Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase\/AKT\/Ras homolog enriched in brain (Rheb)\/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation","volume":"279","author":"Alam","year":"2004","journal-title":"J Biol Chem"},{"key":"2019061221400634600_bib34","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1210\/en.2008-0850","article-title":"Role of the phosphatidylinositol-3-kinase and extracellular regulated kinase pathways in the induction of hypoxia-inducible factor (HIF)-1 activity and the HIF-1 target vascular endothelial growth factor in ovarian granulosa cells in response to follicle-stimulating hormone","volume":"150","author":"Alam","year":"2009","journal-title":"Endocrinology"},{"key":"2019061221400634600_bib35","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/cr.2008.70","article-title":"Activation of the PI3K\/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma","volume":"18","author":"Huang","year":"2008","journal-title":"Cell Res"},{"key":"2019061221400634600_bib36","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1097\/IGC.0000000000000279","article-title":"Follicle-stimulating hormone induced epithelial-mesenchymal transition of epithelial ovarian cancer cells through follicle-stimulating hormone receptor PI3K\/Akt-Snail signaling pathway","volume":"24","author":"Yang","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"2019061221400634600_bib37","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ctrv.2018.07.013","article-title":"Everolimus-based combination therapies for HR+, HER2- metastatic breast cancer","volume":"69","author":"O\u2019Shaughnessy","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"2019061221400634600_bib38","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1200\/JCO.2011.39.0708","article-title":"Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: a GINECO study","volume":"30","author":"Bachelot","year":"2012","journal-title":"J Clin Oncol"},{"key":"2019061221400634600_bib39","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/humrep\/dex027","article-title":"The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review","volume":"32","author":"Rodgers","year":"2017","journal-title":"Hum Reprod"},{"key":"2019061221400634600_bib40","first-page":"192","article-title":"Expression of follicle stimulating hormone receptors in intra-tumoral vasculature and in tumoral cells - the involvement in tumour progression and the perspectives of application in cancer diagnosis and therapy","volume":"69","author":"Pawlikowski \u0141\u00f3d\u017a","year":"2018","journal-title":"Endokrynol Pol"},{"key":"2019061221400634600_bib41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fendo.2011.00045","article-title":"Mapping the follicle-stimulating hormone-induced signaling networks","volume":"2","author":"Gloaguen","year":"2011","journal-title":"Front Endocrin"},{"key":"2019061221400634600_bib42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13046-015-0128-7","article-title":"Endothelial follicle-stimulating hormone receptor expression in invasive breast cancer and vascular remodeling at tumor periphery","volume":"34","author":"Planeix","year":"2015","journal-title":"J Exp Clin Cancer Res"},{"key":"2019061221400634600_bib43","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ijc.20478","article-title":"Follicle stimulating hormone-induced growth promotion and gene expression profiles on ovarian surface epithelial cells","volume":"112","author":"Ji","year":"2004","journal-title":"Int J Cancer"},{"key":"2019061221400634600_bib44","first-page":"851","article-title":"Novel evidence that pituitary sex hormones regulate migration, adhesion, and proliferation of embryonic stem cells and teratocarcinoma cells","volume":"39","author":"Sellers","year":"2018","journal-title":"Oncol Rep"},{"key":"2019061221400634600_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/5096596","article-title":"Novel action of FSH on stem cells in adult mammalian ovary induces postnatal oogenesis and primordial follicle assembly","volume":"2016","author":"Bhartiya","year":"2016","journal-title":"Stem Cells Int"},{"key":"2019061221400634600_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/8530207","article-title":"Effective mobilization of very small embryonic-like stem cells and hematopoietic stem\/progenitor cells but not endothelial progenitor cells by follicle-stimulating hormone therapy","volume":"2016","author":"Zbucka-Kretowska","year":"2016","journal-title":"Stem Cells International"},{"key":"2019061221400634600_bib47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.semcdb.2016.08.025","article-title":"Molecular heterogeneity in breast cancer: state of the science and implications for patient care","volume":"64","author":"Ellsworth","year":"2017","journal-title":"Semin Cell Dev Biol"}],"container-title":["Biology of Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/biolreprod\/advance-article-pdf\/doi\/10.1093\/biolre\/ioz050\/28537135\/ioz050.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/biolreprod\/article-pdf\/100\/6\/1521\/28797760\/ioz050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T21:41:20Z","timestamp":1560375680000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biolreprod\/article\/100\/6\/1521\/5424732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,2]]},"references-count":47,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,4,2]]},"published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/biolre\/ioz050","relation":{},"ISSN":["0006-3363","1529-7268"],"issn-type":[{"value":"0006-3363","type":"print"},{"value":"1529-7268","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6]]},"published":{"date-parts":[[2019,4,2]]}}}